Lymphatic permeation and vascular invasion should not be integrated as lymphovascular invasion in lung adenocarcinoma.
Yusuke SugitaTomonari KinoshitaToshiyuki ShimaNaomichi SasakiMao UematsuReiko ShimizuMasahiko HaradaTsunekazu HishimaHirotoshi HorioPublished in: General thoracic and cardiovascular surgery (2021)
LY and VI have differing effects postoperative prognosis and recurrence-relevant events, suggesting that these pathological findings should not be integrated as LVI.